Status:
COMPLETED
A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients.
Lead Sponsor:
Cairo University
Conditions:
Vitiligo
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
A comparative study on the efficacy of blue light emitting diodes therapy versus targeted Narrow band UVB in stable non-segmental vitiligo patients.
Detailed Description
A comparative study on the efficacy of blue light emitting diodes therapy versus targeted Narrow band UVB in stable non-segmental vitiligo patients.
Eligibility Criteria
Inclusion
- All age group.
- Both genders.
- Subjects with stable non-segmental vitiligo (≥2 patches) acral or non-acral patches of diameter ≤ 2cm.
Exclusion
- Prior treatment with laser therapies for at least 3 months
- Recent exfoliation procedures.
- Recent surgical procedures.
- Poor skin conditions including keloids.
- Hypersensitivity to light ( visible and near-infrared).
- Medications that make users more sensitive to light.
- Anticoagulant and immunosuppressive treatments.
- Gestations or breastfeeding.
- A personal or family history of skin cancer.
- Unstable vitiligo (older lesions have not progressed for the last 1 years and lack of Koebner phenomena ).
Key Trial Info
Start Date :
January 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 23 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07174024
Start Date
January 20 2025
End Date
August 23 2025
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Giza, Cairo Governorate, Egypt, 13114